Drug resistance in eukaryotic microorganisms.

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Resistance

Background:

• Eukaryotic microbial pathogens cause significant global morbidity and mortality.
• Drug resistance in these pathogens threatens established treatment strategies.
• Challenges in treating eukaryotic pathogens share similarities with prokaryotic antibiotic resistance.

Purpose of the Study:

• To discuss challenges posed by eukaryotic microbial pathogens.
• To compare these challenges with prokaryotic antibiotic resistance.
• To detail therapies and resistance mechanisms for major eukaryotic microorganisms.

Main Methods:

• Review of current therapies for major eukaryotic pathogens.
• Analysis of evolved resistance mechanisms.
• Discussion on integrating new technologies and biological understanding.

Main Results:

• Eukaryotic pathogens evolve resistance, similar to prokaryotes.
• Limited new drug therapies exacerbate the resistance problem.
• Developing nations face acute risks due to resistance and limited treatment options.

Conclusions:

• The emergence of resistance in eukaryotic pathogens is a significant global health risk.
• A restricted pipeline of new antifungal and antiparasitic drugs is a major concern.
• Integrating advanced technologies, biological insights, epidemiology, and evolutionary analysis can sustain therapies and manage resistance.